Stork Therapeutics
San Francisco, US · Founded 2024 · Delaware corporation
Stork Therapeutics is developing CAR T cell therapies to expand the potential of that treatment modality.
Founders & leadership
Stork Therapeutics was founded in 2024 by Gregg Fine.
GF
Gregg FineinChief Executive Officer
MB
Michael BethuneinHead of Discovery Research
NJ
Nayan JainHead of Translational Research
Board
BK
Reported raises · per SEC filings
Form D private placements$1.3M disclosed across 1 round · 2025
▶$1.3MraisedMay 2025 · 3 investors · BiotechnologyRule 506(b)
▶$1.3MraisedMay 2025 · 3 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Brendan KennedyDirector
- Gregg FineExecutive Officer, Director, Promoter
- Offering amount
- $2.7M
- Amount sold
- $1.3M
- First sale
- Apr 2025
- Incorporated
- Corporation, Delaware, 2024
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- What does Stork Therapeutics do?
- Stork Therapeutics is developing CAR T cell therapies to expand the potential of that treatment modality.
- Who founded Stork Therapeutics?
- Stork Therapeutics was founded by Gregg Fine in 2024.
- How much funding has Stork Therapeutics raised?
- Stork Therapeutics has disclosed $1.3M raised across 1 round.
- Where is Stork Therapeutics headquartered?
- Stork Therapeutics is headquartered in San Francisco, US.